Department of Cardiology, Helios Klinikum Wuppertal, Universität Witten/Herdecke, Wuppertal, Germany.
Department of Cardiology, Klinikum Großhadern, Ludwig-Maximilian Universität, Munich, Germany; Department of Cardiology, DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany.
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
This study sought to evaluate the impact of anatomic and procedural variables on the outcome of the unprotected left main coronary artery (uLMCA) itself after drug-eluting stent (DES) implantation.
There is a controversial debate regarding when and how to perform percutaneous coronary intervention (PCI) for an uLMCA stenosis.
This analysis is based on a randomized study of 607 patients undergoing PCI for uLMCA, randomized 1:1 to receive paclitaxel- or sirolimus-eluting stents. We evaluated the impact of the SYNTAX score, uLMCA anatomy, and stenting technique on in-stent restenosis (ISR), target lesion revascularization (TLR), and the 3-year outcomes.
The 3-year cardiac mortality rate was 5.8%; 235 (39%) patients had a true bifurcation lesion (TBL), and the median SYNTAX score was 27. TBL was associated with a higher need for multiple stents (72% vs. 37%, p < 0.001). TBL was a significant predictor of ISR (23% vs. 14%, p = 0.008) and for TLR (18% vs. 9%, p < 0.001). The need for multiple stents was a predictor of ISR (22% vs. 13%, p = 0.005) and for TLR (16% vs. 9%, p = 0.005). Culotte stenting showed better results compared with T-stenting for ISR (21% vs. 56%, p = 0.02) and for TLR (15% vs. 56%, p < 0.001). We observed a significant association between uLMCA-TLR and SYNTAX scores (9.2% for scores ≤ 22, 14.9% for scores 23 to 32, and 13.0% for scores ≥ 33, p = 0.008).
PCI of uLMCA lesions with DES is safe and effective out to 3 years. TBL and multiple stents were independent predictors for ISR. In the multivariate analysis, independent predictors for TLR were TBL, age, and EuroSCORE (European System for Cardiac Operative Risk Evaluation). (Drug-Eluting-Stents for Unprotected Left Main Stem Disease [ISAR-LEFT-MAIN]; NCT00133237).
本研究旨在评估解剖学和程序变量对药物洗脱支架(DES)植入后无保护左主干冠状动脉(uLMCA)本身的结果的影响。
对于 uLMCA 狭窄何时以及如何进行经皮冠状动脉介入治疗(PCI)存在争议。
本分析基于 607 例接受 uLMCA PCI 的随机研究,1:1 随机接受紫杉醇或西罗莫司洗脱支架。我们评估了 SYNTAX 评分、uLMCA 解剖结构和支架技术对支架内再狭窄(ISR)、靶病变血运重建(TLR)和 3 年结果的影响。
3 年心脏死亡率为 5.8%;235 例(39%)患者存在真性分叉病变(TBL),中位 SYNTAX 评分为 27。TBL 与需要多支架置入相关(72% vs. 37%,p < 0.001)。TBL 是 ISR(23% vs. 14%,p = 0.008)和 TLR(18% vs. 9%,p < 0.001)的显著预测因素。需要多支架置入是 ISR(22% vs. 13%,p = 0.005)和 TLR(16% vs. 9%,p = 0.005)的预测因素。Culotte 支架置入术与 T 支架置入术相比,ISR(21% vs. 56%,p = 0.02)和 TLR(15% vs. 56%,p < 0.001)的结果更好。我们观察到 uLMCA-TLR 与 SYNTAX 评分之间存在显著相关性(评分≤22 为 9.2%,评分 23 至 32 为 14.9%,评分≥33 为 13.0%,p = 0.008)。
DES 治疗 uLMCA 病变的 PCI 治疗在 3 年内是安全有效的。TBL 和多支架置入是 ISR 的独立预测因素。在多变量分析中,TLR 的独立预测因素是 TBL、年龄和欧洲心脏手术风险评估系统(EuroSCORE)。(药物洗脱支架治疗无保护左主干病变[ISAR-LEFT-MAIN];NCT00133237)。